Genpharmasec Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1992.
1992 Mumbai, Maharashtra, India Active
Last Updated:
About Genpharmasec Limited

Genpharmasec Limited, a active public limited company, was established on 16 November 1992 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: L24231MH1992PLC323914. Registered under ROC Roc Mumbai. it is listed on BSE: 531592. It has an authorized capital of ₹56.00 Cr and a paid-up capital of ₹55.37 Cr.

Formerly known as Generic Pharmasec Limited, Adi Rasayan Limited. It upholds a compliant status. In 2023, it reported revenue of ₹25.62 Cr and a net worth of ₹15.33 Cr. Its leadership includes Mayur Bharatbhai Bhatt (Director), Sachin Prakash Aphandkar (Director), Hardik Pravinbhai Makwana (Company Secretary). Past directors included Mayur Bharatbhai Bhatt, Sachin Prakash Aphandkar, Amisha Mitesh Dani. It holds ₹6.50 Cr open charges and ₹26.35 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No. 104 & 105 1St Floor Gundecha Industrial Premises Co-Op Soc. Ltd.Akurli Road Kand, Ivali East, Mumbai, Maharashtra, 400101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24231MH1992PLC323914

  • Registration Number

    323914

  • Incorporation Date

    16 November 1992

  • Authorized Capital

    ₹56.00 Cr

  • Paid-Up Capital

    ₹55.37 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Listed (BSE: 531592)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 56.00 Cr
  • Paid Up Capital ₹ 55.37 Cr
  • Company Age 33 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.50 Cr
  • Satisfied Charges ₹ 26.35 Cr
  • Revenue Growth **** -6.56%
  • Profit Growth **** 637.41%
  • Ebitda **** 149.34%
  • Net Worth -0.26%
  • Total Assets -8.20%
Company report

Genpharmasec Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Genpharmasec Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Genpharmasec Limited?
Current Directors
Name Designation Appointment Date Status
Mayur Bharatbhai Bhatt Director 01 Nov 2022 Current
Sachin Prakash Aphandkar Director 01 Nov 2022 Current
Hardik Pravinbhai Makwana Company Secretary 27 Mar 2024 Current
Siddhesh Shankar Shende Director 04 Jul 2022 Current
Sohan Chaturvedi Whole-Time Director 26 Apr 2024 Current
Rajesh Mirchumal Sadhwani Director 02 Jan 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 27 Feb 2023 Past
Pramod Abcsdd Additional Director 22 Dec 2020 Past
Pramod Abcsdd Director 07 Oct 2022 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Cfo(Kmp) - Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genpharmasec.

Genpharmasec Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.56% decrease. The company also saw a substantial improvement in profitability, with a 637.41% increase in profit. The company's net worth dipped by a decrease of 0.26%.

Genpharmasec revenue growth over time
Genpharmasec profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-6.56%
*******
*******
*******
*******
Revenue from Operations
*******
-6.61%
*******
*******
*******
*******
Total Assets
*******
-8.20%
*******
*******
*******
*******
Profit or Loss
*******
637.41%
*******
*******
*******
*******
Net Worth
*******
-0.26%
*******
*******
*******
*******
EBITDA
*******
149.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genpharmasec?

In 2022, Genpharmasec had a promoter holding of 59.96% and a public holding of 40.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹65,000,000.00

Satisfied Charges

₹263,500,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 4.00 Cr
  • Others : 2.50 Cr
Latest Charge Details
Date Lender Amount Status
03 Jul 2025 Hdfc Bank Limited ₹1.50 Cr Open
23 May 2025 Hdfc Bank Limited ₹2.50 Cr Open
06 May 2025 Others ₹2.50 Cr Open
24 May 2023 Others ₹3.00 Cr Satisfied
12 Feb 1996 International Asset Reconstruction Company Pvt. Ltd. ₹8.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Genpharmasec?

Unlock and access historical data on people associated with Genpharmasec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genpharmasec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genpharmasec's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genpharmasec
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 24 May 2023 via Charge ID 100721350 with Others was fully satisfied on 17 Dec 2025. was completed.

  • Annual General Meeting

    Genpharmasec Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 1.50 Cr with Charge ID 101120161 was registered on 03 Jul 2025. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.50 Cr with Charge ID 101104542 was registered on 23 May 2025. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 2.50 Cr with Charge ID 101108946 was registered on 06 May 2025. was documented.

  • Balance Sheet

    Progress on Genpharmasec Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Genpharmasec Limited?

The CIN of Genpharmasec Limited is L24231MH1992PLC323914.

Where is Genpharmasec Limited headquartered?

Genpharmasec Limited is headquartered at Office No. 104 & 105 1St Floor Gundecha Industrial Premises Co-Op Soc. Ltd.Akurli Road Kand, Ivali East, Mumbai, Maharashtra, 400101.

When was Genpharmasec Limited incorporated?

Genpharmasec Limited was incorporated on 16 November 1992.

Who are the current directors of Genpharmasec Limited?

The current directors of Genpharmasec Limited are

What is the primary industry of Genpharmasec Limited?

The primary industry of Genpharmasec Limited is Trade.

Is Genpharmasec Limited a listed company?

Genpharmasec Limited is listed. It is listed on BSE: 531592.

What is the capital structure of Genpharmasec Limited?

The authorized capital of Genpharmasec Limited is ₹56.00 Cr, and the paid-up capital is ₹55.37 Cr.

What is the compliance status of Genpharmasec Limited?

The compliance status of Genpharmasec Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available